Richard Peters

Insider Reports History

Entity
Individual
Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Signature
/s/ Nanette Agustines, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Peters:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. Director Common Stock 2.07K $15.1K $7.29 Jun 20, 2024 Direct
KINETA, INC./DE Director Stock Option (Right to Buy) 12.5K Sep 4, 2024 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 20, 2024 Direct

Insider Reports Filed by Richard Peters

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KA KINETA, INC./DE Sep 4, 2024 1 $0 4 Sep 5, 2024 Director
APRE Aprea Therapeutics, Inc. Jun 20, 2024 2 $0 4 Jun 21, 2024 Director
APRE Aprea Therapeutics, Inc. Aug 23, 2023 2 $0 4 Aug 24, 2023 Director
KA KINETA, INC./DE Apr 12, 2023 2 $0 4 Apr 14, 2023 Director
KA KINETA, INC./DE Dec 16, 2022 1 -$3.59K 4 Dec 20, 2022 Director
KA YUMANITY THERAPEUTICS, INC. Dec 2, 2022 1 -$18.4K 4 Dec 6, 2022 President and CEO, Director
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Director
KA YUMANITY THERAPEUTICS, INC. Jul 5, 2022 1 -$8.48K 4 Jul 6, 2022 President and CEO, Director
KA YUMANITY THERAPEUTICS, INC. Jun 3, 2022 1 -$12.2K 4 Jun 6, 2022 President and CEO, Director
KA YUMANITY THERAPEUTICS, INC. Mar 28, 2022 1 -$19.8K 4 Mar 30, 2022 President and CEO, Director
KA YUMANITY THERAPEUTICS, INC. Dec 1, 2021 1 $0 4 Dec 3, 2021 President and CEO, Director
KA YUMANITY THERAPEUTICS, INC. Jul 2, 2021 2 -$50.2K 4 Jul 7, 2021 President and CEO, Director
APRE Aprea Therapeutics, Inc. Jun 30, 2021 2 $0 4 Jul 1, 2021 Director